MAUDE MDR 9598252

MDR report key
9598252
Report number
1628664-2020-00019
Event key
0
Event type
3
Date of event
2019-08-23
Date received
2020-01-16
Adverse event
3
Product problem
3
Patients in event
0
Reporter occupation
100
Health professional
3
Initial report to FDA
3
Event location
3

Manufacturer Contact#

Contact
CHRISTIAN LEE
Address
100 ABBOTT PARK ROAD DEPT 09B9, BLDG CP01-3 ABBOTT PARK IL 60064 US
Phone
224-224-2246
Report source
M
Manufacturer link flag
Y

Devices#

Seq, Brand, Generic table
SeqBrandGenericManufacturerProduct codeModelCatalogLotPMA510(k)ImplantEvaluatedAvailability
1CALCIUMCALCIUMABBOTT MANUFACTURING INCCJY3L79-2103L79-2161158UN18Y N

Patients#

Sequence, Received, Treatment table
SequenceReceivedTreatmentOutcome
12020-01-1601. R

Event Narratives#

N

Patient 1

AN EVALUATION IS IN PROCESS. A FOLLOW UP REPORT WILL BE SUBMITTED WHEN THE EVALUATION IS COMPLETED.

D

Patient 1

THE ACCOUNT GENERATED FALSE ELEVATED ARCHITECT CALCIUM OF 3.03 MMOL/L WITH SID (B)(6) ON (B)(6) 2019 MORNING ON A (B)(6)-YEAR OLD CAUCASIAN FEMALE LUNG CANCER PROGRESSIVE MALIGNANCY PATIENT WHO WAS TREATED WITH APD INFUSION (BIPHOSPHONATES INFUSION - PAMIDRONATES) DUE TO THE ELEVATED CALCIUM RESULT. THE SAMPLE REPEATED ARCHITECT CALCIUM OF 2.46 MMOL/L ON (B)(6) 2019 AT 15:35 WHICH WAS THE CORRECT RESULT REPORTED TO THE PHYSICIAN BUT THE APD INFUSION HAD FINISHED. ADDITIONAL TESTING WAS CALCIUM OF 2.33 MMOL/L ON (B)(6) 2019 AND 2.16 MMOL/L ON (B)(6) 2019. PRIOR TO APD INFUSION, THE PATIENT WAS VERY SICK. DAYS AFTER THE APD INFUSION, THE PATIENT WENT TO THE HOSPITAL WITH FEVER, DID NOT FEEL WELL AND BLAMED THE APD INFUSION. THE PATIENT RECEIVED AMOXI IV AS TREATMENT FOR THE FEVER. THE PATIENTS PLANNED CHEMOTHERAPY WAS POSTPONED 7 DAYS DUE TO THE ELEVATED CALCIUM RESULT. HISTORICAL PATIENT CALCIUM WAS 2.32 MMOL/L ((B)(6) 2002), 2.43 MMOL/L ((B)(6) 2002), 2.42 MMOL/L ((B)(6) 2002), 2.37 MMOL/L ((B)(6) 2002), 2.33 MMOL/L ((B)(6) 2003), 2.24 MMOL/L ((B)(6) 2018), 2.37 MMOL/L ((B)(6) 2019), 2.41 MMOL/L ((B)(6) 2019), 2.40 MMOL/L ((B)(6) 2019), 2.43 MMOL/L ((B)(6) 2019), 2.45 MMOL/L ((B)(6) 2019), 2.55 MMOL/L ((B)(6) 2019), 2.46 MMOL/L ((B)(6) 2019), 2.43 MMOL/L ((B)(6) 2019), 2.47 MMOL/L ((B)(6) 2019), 2.44 MMOL/L ((B)(6) 2019), 2.48 MMOL/L ((B)(6) 2019), 2.55 MMOL/L ((B)(6) 2019), 2.39 MMOL/L ((B)(6) 2019). THE ACCOUNT USES A CALCIUM REFERENCE RANGE OF 2.10 TO 2.65 MMOL/L.